Panel Says Substantial Evidence Supports Board’s Patent Obviousness Ruling
WASHINGTON, D.C. — A patented method of treating pulmonary hypertension was correctly deemed obvious by the Patent Trial and Appeal Board, the Federal Circuit U.S. Court of Appeals ruled Dec. 20...To view the full article, register now.
Already a subscriber? Click here to view full article